Medicare Enrolled
Dr. Nani Kanen
Internal Medicine · Burlingame, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kanen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kanen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kanen
Dr. Nani Kanen is an internal medicine specialist in Burlingame, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kanen performed 9,407 Medicare services across 1,681 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kanen received a total of $11,877 from 64 pharmaceutical and/or device companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kanen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$11,877 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,407
Medicare services
Top 3% in CA for internal medicine
1,681
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~495 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 6,120 | $19 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,097 | $110 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
335 | $14 | $50 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
235 | $52 | $125 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
206 | $91 | $149 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
205 | $8 | $16 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
193 | $156 | $228 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
160 | $1 | $10 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
144 | $12 | $60 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $77 | $180 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
97 | $163 | $350 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
92 | $107 | $300 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
87 | $35 | $41 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
80 | $72 | $150 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
48 | $227 | $407 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
44 | $14 | $90 |
| New patient office visit, complex (60-74 min) | 44 | $184 | $353 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
26 | $4 | $25 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 26 | $256 | $412 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $143 | $450 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
14 | $131 | $219 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
14 | $37 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,877
Total received (2018-2024)
Avg $1,697/year across 7 years
Top 9% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
664
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,877 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,474
2023
$1,996
2022
$1,578
2021
$2,048
2020
$1,450
2019
$1,121
2018
$1,212
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$427
Novo Nordisk Inc
$405
AstraZeneca Pharmaceuticals LP
$176
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$169
Otsuka America Pharmaceutical, Inc.
$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$135
IDORSIA PHARMACEUTICALS US INC
$122
Takeda Pharmaceuticals U.S.A., Inc.
$116
Lilly USA, LLC
$94
PFIZER INC.
$82
Collegium Pharmaceutical, Inc.
$76
Indivior Inc.
$74
Braeburn Inc.
$55
GlaxoSmithKline, LLC.
$54
Amgen Inc.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Vanda Pharmaceuticals Inc.
$33
Phathom Pharmaceuticals, Inc.
$32
Dexcom, Inc.
$24
Alkermes, Inc.
$23
Axsome Therapeutics, Inc.
$22
Verity Pharmaceuticals Inc.
$22
MERZ NORTH AMERICA, INC.
$21
Neurocrine Biosciences, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$18
Abbott Laboratories
$17
Bausch Health US, LLC
$16
SCILEX PHARMACEUTICALS INC.
$14
Top 3 companies account for 40.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,274
ABBVIE INC.
$907
AstraZeneca Pharmaceuticals LP
$791
Collegium Pharmaceutical, Inc.
$660
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$603
Indivior Inc.
$596
Lilly USA, LLC
$430
Takeda Pharmaceuticals U.S.A., Inc.
$399
GlaxoSmithKline, LLC.
$397
AbbVie Inc.
$383
Astellas Pharma US Inc
$326
Bausch Health US, LLC
$322
Sunovion Pharmaceuticals Inc.
$281
Janssen Pharmaceuticals, Inc
$271
Allergan, Inc.
$228
IDORSIA PHARMACEUTICALS US INC
$228
Boehringer Ingelheim Pharmaceuticals, Inc.
$225
Alkermes, Inc.
$217
Otsuka America Pharmaceutical, Inc.
$211
PFIZER INC.
$200
Teva Pharmaceuticals USA, Inc.
$163
Merck Sharp & Dohme Corporation
$155
Novartis Pharmaceuticals Corporation
$151
Eisai Inc.
$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$135
Galderma Laboratories, L.P.
$134
Allergan Inc.
$123
Amgen Inc.
$120
Merck Sharp & Dohme LLC
$118
Amarin Pharma Inc.
$118
Daiichi Sankyo Inc.
$117
Gilead Sciences, Inc.
$111
AbbVie, Inc.
$100
SANOFI-AVENTIS U.S. LLC
$87
MERZ NORTH AMERICA, INC.
$75
Avanir Pharmaceuticals, Inc.
$65
Orexo US, Inc.
$62
Lundbeck LLC
$62
Arbor Pharmaceuticals, Inc.
$61
Kowa Pharmaceuticals America, Inc.
$60
Hikma Pharmaceuticals USA
$58
Braeburn Inc.
$55
ITI, Inc.
$55
Vanda Pharmaceuticals Inc.
$54
Abbott Laboratories
$52
Medtronic, Inc.
$50
BOSTON SCIENTIFIC CORPORATION
$47
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$46
Biohaven Pharmaceuticals, Inc.
$33
SCILEX PHARMACEUTICALS INC.
$33
Phathom Pharmaceuticals, Inc.
$32
GRT US Holding, Inc.
$30
Dexcom, Inc.
$24
Axsome Therapeutics, Inc.
$22
Verity Pharmaceuticals Inc.
$22
Merz North America, Inc.
$21
Alexion Pharmaceuticals, Inc.
$21
SK Life Science, Inc.
$20
Nalpropion Pharmaceuticals LLC
$20
Neurocrine Biosciences, Inc.
$19
Alfasigma USA, Inc.
$16
Titan Pharmaceuticals, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$13
Forte Bio-Pharma LLC
$13
Top 3 companies account for 25.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AIMOVIG · AIRSUPRA · ANORO · APLENZIN · AREXVY · AUSTEDO · Aimovig · AirDuo Digihaler · Amitiza · Auvelity · BASAGLAR · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · BOTOX · BREZTRI · BRINTELLIX · BRIXADI · BUNAVAIL · BYSTOLIC · Belbuca · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CREON · Creon · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · ENTRESTO · Edarbi · FANAPT · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · INGREZZA · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · KYNMOBI · Kloxxado · LATUDA · LINZESS · LUCEMYRA · Livalo · MOUNJARO · MYFEMBREE · MYRBETRIQ · Mitigare · Morphabond ER · Myrbetriq · NALOCET · NURTEC ODT · Nuedexta · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR 13 · PROCLAIM · Probuphine · QULIPTA · QUVIVIQ · Qutenza · RELISTOR · REXULTI · RYBELSUS · Repatha · Rybelsus · SEEBRI · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · STRENSIQ · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SYMBICORT · SYNTHROID · Saxenda · TEPEZZA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tlando · Tresiba · Trintellix · UBRELVY · UTIBRON · Uloric · Utibron · VIIBRYD · VIVITROL · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Vivitrol · Vivitrol 380 mg · Vyvanse · WAVEWRITER ALPHA · Wegovy · XARELTO · XIFAXAN · XTAMPZA · XTAMPZAER · Xeomin · ZORYVE · ZTLido · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
3,537
Per 100K population
474.7
County median income
$156,000
Nearest hospital
PENINSULA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kanen is a clinical cardiology specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kanen experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kanen performed 6,120 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kanen receive payments from pharmaceutical companies?
Yes. Dr. Kanen received a total of $11,877 from 64 companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kanen's costs compare to other internal medicine physicians in Burlingame?
Dr. Kanen's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kanen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Burlingame
Browse internal medicine physicians in Burlingame ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology